Matrix Pharmaceutical, Inc. manufactures novel drug product candidates for cancer based on its internal research and development capabilities and through in licensing of product candidates from research institutions or other pharmaceutical companies. The company also specializes in contract aseptic manufacturing for clinical and commercial supply. Matrix had developed an aqueous-based protein gel system for delivery of water-s...
Matrix Pharmaceutical, Inc. manufactures novel drug product candidates for cancer based on its internal research and development capabilities and through in licensing of product candidates from research institutions or other pharmaceutical companies. The company also specializes in contract aseptic manufacturing for clinical and commercial supply. Matrix had developed an aqueous-based protein gel system for delivery of water-soluble chemotherapeutic agents and non-aqueous semi-solid systems for delivery of chemotherapeutic agents that are poorly water-soluble. Two product candidates that utilize the aqueous-based protein gel systems are being evaluated in human clinical trials. Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz, two companies with a rich and diverse corporate history. Throughout the years, Novartis and its predecessor companies have discovered and developed many innovative products for patients and consumers worldwide.
Novartis has been in India since 1947. The Group operates in India through four entities namely Novartis India Limited, listed on the Mumbai Stock Exchange, Novartis Healthcare Private Limited, Sandoz Private Limited and Chiron-Behring Vaccine Private Limited. In India Novartis has a presence in pharmaceuticals, generics (pharmaceutical products that are off patent), Vaccines, OTC (over-the-counter medicines), eyecare and Animal Health.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.